Literature DB >> 29913754

Psychiatric (axis I) and personality (axis II) disorders in patients with burning mouth syndrome or atypical facial pain.

Tero Taiminen1, Laura Kuusalo1, Laura Lehtinen1, Heli Forssell2, Nora Hagelberg3, Olli Tenovuo4, Sinikka Luutonen1, Antti Pertovaara5, Satu Jääskeläinen6.   

Abstract

Background and aims Burning mouth syndrome (BMS) and atypical facial pain (AFP) are often persistent idiopathic pain conditions that mainly affect middle-aged and elderly women. They have both been associated with various psychiatric disorders. This study examined current and lifetime prevalence of psychiatric axis I (symptom-based) and II (personality) disorders in patients with chronic idiopathic orofacial pain, and investigated the temporal relationship of psychiatric disorders and the onset of orofacial pain. Method Forty patients with BMS and 23 patients with AFP were recruited from Turku university hospital clinics. Mean age of the patients was 62.3 years (range 35-84) and 90% were female. BMS and AFP diagnoses were based on thorough clinical evaluation, and all patients had undergone clinical neurophysiological investigations including blink reflex and thermal quantitative tests. Current and lifetime DSM-IV diagnoses of axis I and II disorders were made on clinical basis with the aid of SCID-I and II-interviews. The detected prevalence rates and their 95% confidence intervals based on binomial distribution were compared to three previous large population-based studies. Results Of the 63 patients, 26 (41.3%) had had an axis I disorder that preceded the onset of orofacial pain, and 33 (52.4%) had had a lifetime axis I disorder. Rate of current axis I disorders was 36.5%, indicating that only about 16% of lifetime disorders had remitted, and they tended to run chronic course. The most common lifetime axis I disorders were major depression (30.2%), social phobia (15.9%), specific phobia (11.1%), and panic disorder (7.9%). Twelve patients (19.0%) had at least one cluster C personality disorder already before the emergence of orofacial pain. Patients with cluster C personality disorders are characterized as fearful and neurotic. None of the patients had cluster A (characterized as odd and eccentric) or B (characterized as dramatic, emotional or erratic) personality disorders. The most common personality disorders were obsessive-compulsive personality (14.3%), dependent personality (4.8%), and avoidant personality (3.2%). The majority of the patients (54%) had also one or more chronic pain conditions other than orofacial pain. In almost all patients (94%) they were already present at the onset of orofacial pain. Conclusions Our results suggest that major depression, persistent social phobia, and neurotic, fearful, and obsessive-compulsive personality characteristics are common in patients with chronic idiopathic orofacial pain. Most psychiatric disorders precede the onset of orofacial pain and they tend to run a chronic course. Implications We propose that the high psychiatric morbidity, and comorbidity to other chronic pain conditions, in chronic idiopathic orofacial pain can be best understood in terms of shared vulnerability to both chronic pain and specific psychiatric disorders, most likely mediated by dysfunctional brain dopamine activity.

Entities:  

Keywords:  Atypical facial pain; Burning mouth syndrome; Chronic pain; Persistent idiopathic facial pain; Personality disorder; Psychiatric disorder

Year:  2011        PMID: 29913754     DOI: 10.1016/j.sjpain.2011.06.004

Source DB:  PubMed          Journal:  Scand J Pain        ISSN: 1877-8860


  8 in total

1.  Feasibility and reliability of intraorally evoked "nociceptive-specific" blink reflexes.

Authors:  Rajath Sasidharan Pillai; Cung May Thai; Laura Zweers; Michail Koutris; Frank Lobbezoo; Yuri Martins Costa; Maria Pigg; Thomas List; Peter Svensson; Lene Baad-Hansen
Journal:  Clin Oral Investig       Date:  2019-06-24       Impact factor: 3.573

Review 2.  Interventions for treating burning mouth syndrome.

Authors:  Roddy McMillan; Heli Forssell; John Ag Buchanan; Anne-Marie Glenny; Jo C Weldon; Joanna M Zakrzewska
Journal:  Cochrane Database Syst Rev       Date:  2016-11-18

3.  Development of an interdisciplinary specialist facial pain management programme.

Authors:  John Tetlow; Christian Ainsley; Hannah Twiddy; Graham Derbyshire; Rajiv Chawla
Journal:  Br J Pain       Date:  2021-07-19

4.  Challenges of Misdiagnosis and Suboptimal Treatment of Persistent Idiopathic Facial Pain and Atypical Odontalgia: A Retrospective Multi-Centric Cross-Sectional Investigation.

Authors:  Xiong Xiao; Lei Jiang; Longjun Liu; Guoliang Chai; Fang Luo
Journal:  J Pain Res       Date:  2020-11-10       Impact factor: 3.133

5.  The analgesic effect of therapeutic rTMS is not mediated or predicted by comorbid psychiatric or sleep disorders.

Authors:  Pauliina Lindholm; Salla Lamusuo; Tero Taiminen; Arja Virtanen; Antti Pertovaara; Heli Forssell; Nora Hagelberg; Satu Jääskeläinen
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

6.  Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine.

Authors:  Satoshi Kasahara; Chihiro Takao; Ko Matsudaira; Naoko Sato; Trang Thi Huyen Tu; Shin-Ichi Niwa; Kanji Uchida; Akira Toyofuku
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-22

7.  Differences in the Clinical Characteristics of Persistent Idiopathic Facial Pain (Atypical Odontalgia) Patients with or Without Neurovascular Compression of the Trigeminal Nerve.

Authors:  Kaoru Kawasaki; Shiori Sugawara; Kazuya Watanabe; Chaoli Hong; Trang Thi Huyen Tu; Takeshi Watanabe; Junichiro Sakamoto; Norio Yoshino; Takayuki Suga; Lou Mikuzuki; Miho Takenoshita; Satoshi Takada; Tohru Kurabayashi; Akira Toyofuku
Journal:  Pain Med       Date:  2020-04-01       Impact factor: 3.750

8.  The Role of Facial Expression Analysis and Electrodermal Activity as an Objective Evaluation of Persistent Idiopathic Facial Pain.

Authors:  Jan Pavel Rokicki; Andrius Ivanauskas; Gintaras Janužis
Journal:  J Craniofac Surg       Date:  2022 Jan-Feb 01       Impact factor: 1.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.